Ultragenyx's Gene Therapy for Sanfilippo Syndrome Receives FDA Acceptance
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
Editorial Staff Apr 19
The Rise of School Choice in Iowa: Implications for Students
As school choice initiatives gain traction in Iowa and nationwide, Cedar Rapids serves as a case study on the potential impacts of market-driven education.
Editorial Staff Apr 19
Medicare Advantage Spending in Puerto Rico Rises by $865 Million Without Improvement in Plans
Despite a notable increase in Medicare Advantage spending in Puerto Rico, the expected improvements in plan quality have not materialized.
Editorial Staff Apr 19
Insights on Drug Pricing and Healthcare Policies from Health Affairs
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
Editorial Staff Apr 19
Positive Outcomes from ACO Program Focused on Equity and Community Health
The first year of the ACO program aimed at enhancing equity and community health has shown promising results, according to Health Affairs.
Editorial Staff Apr 19
Analyzing Patient Cost Sharing Trends and Their Impact on Hospital Revenue
A recent analysis explores how changing patient cost-sharing practices are affecting the financial stability of both urban and rural hospitals.
Editorial Staff Apr 19
Maryland's Hospital Utilization Drops Significantly Under Global Budgets
A recent study highlights a notable decline in hospital utilization in Maryland, showing an 11 percentage point decrease compared to other states from 2013 to 2023.
Editorial Staff Apr 19
Examining Two Decades of US Spending on Mental Health and Substance Use Treatment
A recent analysis highlights the trends in national spending on mental health and substance use disorder treatment from 2000 to 2021, reflecting case growth over the years.
Editorial Staff Apr 19
Revolution Medicines' Daraxonrasib Shows Promise in Pancreatic Cancer Treatment
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
Editorial Staff Apr 19
Trump's Push for Psychedelic Treatment Access and Reevaluation
In a recent directive, Trump has called on federal agencies to expedite access to psychedelic treatments and reconsider their classification as controlled substances.
Editorial Staff Apr 18
Bridging the Gap: MAHA and Public Health in Dialogue
The podcast 'Why Should I Trust You?' emphasizes the need for communication between MAHA and public health, highlighting the stakes involved.
Editorial Staff Apr 18
Mixed Feelings Surround Trump's CDC Appointment Amid RFK Jr. Concerns
While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.
Editorial Staff Apr 18
The Road to the 2026 Stanley Cup: Insights on the Playoff Teams
As the 2026 Stanley Cup playoffs approach, anticipation builds. Fans eagerly await to see which of the 16 competing teams will claim the coveted title.
Editorial Staff Apr 17
Analyzing Trends in Employer-Sponsored Health Insurance Coverage
A recent analysis reveals trends in employer-based health insurance, affecting 165.6 million individuals under 65 years old as of March 2025.
Editorial Staff Apr 17
Truist Revises Outlook for Community Health Systems Amid Sector Changes
In a recent update, Truist has adjusted its outlook for Community Health Systems, Inc. as part of a broader review of the healthcare sector.
Editorial Staff Apr 17
Understanding Vaccine Trust: A Closer Look at Recent Polls
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
Editorial Staff Apr 17
The Vulnerability of Health Care to AI-Driven Cyber Threats
As cyberattacks on health care systems escalate, the potential for patient harm grows. Andrea Downing highlights the urgent need for improved defenses against these threats.
Editorial Staff Apr 17
EU Reduces Contribution to Global Fund Amid Global Health Aid Cuts
As international donors reduce their support, the European Commission has committed €700 million to the Global Fund, which focuses on combating AIDS, Tuberculosis, and Malaria.
Editorial Staff Apr 8
Current Trends in MAHA: Breakthroughs and Challenges
Recent updates on MAHA highlight a significant breakthrough in Duchenne muscular dystrophy, alongside ongoing challenges in cancer treatment and other health developments.
Editorial Staff Apr 8
Reviving Hope: A Mother's Fight for Neuromuscular Drug Class
A mother's determination has reignited interest in a neglected class of drugs, potentially benefiting her son and many others with neuromuscular disorders.
Editorial Staff Apr 8